Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan-Reference-Cited by-同舟云学术

Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan

Published:2023-11 Issue: Volume: Page:
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Akiyama Yutaro^ORCID,Morioka Shinichiro^ORCID,Tsuzuki Shinya^ORCID,Yoshikawa Tomoki,Yamato Masaya,Nakamura Hideta,Shimojima Masayuki,Takakusaki Mizue,Saito Sho,Takahashi Kozue,Sanada Mio,Komatsubara Mika,Takebuchi Kaoru,Yamaguchi Etsuko,Suzuki Tetsuya^ORCID,Shimokawa Komei,Kurosu Takeshi,Kawahara Madoka^ORCID,Oishi Kohei^ORCID,Ebihara Hideki^ORCID,Ohmagari Norio

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference14 articles.

1. Who. Multi-country outbreak of mpox, External situation Report #21 27 April 2023. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-21---27-april-2023.

2. Clinical presentation of Mpox in people with and without HIV in the United Kingdom during the 2022 global outbreak;Pilkington;AIDS Res Hum Retrovir,2023

3. Monkeypox virus isolation from longitudinal samples from four patients to infer risk of onwards transmission: an interim analysis;Callaby;J Hosp Infect,2023

4. Therapeutics for treating mpox in humans;Fox;Cochrane Database Syst Rev,2023

5. Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox;Suzuki;BMJ Open,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023;NEJM Evidence;2024-09-13

2. Scars are frequently found as late sequelae in individuals affected by the 2022 mpox outbreak;HIV Medicine;2024-05-30